| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |